BP1181

サルメテロール キシナホ酸塩

British Pharmacopoeia (BP) Reference Standard

• 別名: (±) 4-ヒドロキシ-a1-[[[6-(4-フェニルブトキシ)ヘキシル]アミノ]m-エチル]-1,3-ベンゼンジメタノール キシナホ酸塩, GR 33343X キシナホ酸塩
• 実験式（ヒル表記法）: C₂₅H₃₇NO₄ · C₁₁H₈O₃
• CAS番号: 94749-08-3
• 分子量: 603.75
• MDL番号: MFCD00897708
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• 品質水準: 100
• APIファミリー: salmeterol
• 形状: powder
• シェルフライフ: limited shelf life, expiry date on the label
• メーカー／製品名: BP
• アプリケーション: pharmaceutical; pharmaceutical small molecule
• フォーマット: neat
• 保管温度: 2-8°C
• SMILES記法: OC(=O)c1ccc2ccccc2c1O.OCc3cc(ccc3O)C(O)CNCCCCCCOCCCCc4ccccc4
• InChI: 1S/C25H37NO4.C11H8O3/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21;12-10-8-4-2-1-3-7(8)5-6-9(10)11(13)14/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2;1-6,12H,(H,13,14)
• InChI Key: XTZNCVSCVHTPAI-UHFFFAOYSA-N
• 遺伝子情報: human ... ADRB2(154)

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Salmeterol xinafoate BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Fluticasone and Salmeterol Inhalation Powder

Fluticasone and Salmeterol Inhalation Powder, pre-metered

Fluticasone and Salmeterol Pressurised Inhalation, Suspension

生物化学的／生理学的作用

β₂-アドレナリンレセプタ-アゴニスト。

包装

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

その他情報

Sales restrictions may apply.

安全性情報

• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable